» Articles » PMID: 35773636

An Evaluation of Ascitic Calprotectin for Diagnosis of Ascitic Fluid Infection in Children with Cirrhosis

Overview
Journal BMC Pediatr
Publisher Biomed Central
Specialty Pediatrics
Date 2022 Jun 30
PMID 35773636
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The most common infection in children with the hepatic disease with or without cirrhotic ascites is spontaneous bacterial peritonitis (SBP), which occurs in the absence of an evident intra-abdominal source of infection. The present study aims to assess the value of calprotectin in ascitic fluid in the diagnosis of ascitic fluid infection in children with liver cirrhosis.

Materials And Methods: In this cross-section study, 80 children with underlying liver disease who attended the Hepatology and Emergency Department in Shiraz University Hospitals were studied. All the patients were evaluated by a thorough history, clinical examination, laboratory investigations, diagnostic paracentesis with PMNLs count, and Calprotectin, which was measured in 1 mL ascitic fluid by ELISA.

Results: Thirty-five patients (43.75%) were diagnosed with ascitic fluid infection. Of these children 6 cases had positive ascitic fluid culture (SBP). Calprotectin was high in AFI patients with a statistically significant difference in AFI patients compared to non-AFI patients. The cut-off levels were 91.55 mg /L and the area under the curve was 0.971. So it can serve as a sensitive and specific diagnostic test for detection of AFI in children with underlying liver disease.

Conclusion: Elevated ascitic calprotectin levels in cirrhotic patients are a diagnostic and reliable marker for the detection of AFI and are considered a surrogate marker for PMN.

Citing Articles

Ascites fluid calprotectin level is highly accurate in diagnosing spontaneous bacterial peritonitis: a preliminary proof of concept prospective study.

Sbeit W, Maamoun B, Azzam S, Shahin A, Carmiel-Haggai M, Khoury T Clin Exp Med. 2024; 24(1):25.

PMID: 38281236 PMC: 10822801. DOI: 10.1007/s10238-023-01257-0.


Fecal calprotectin in cirrhosis-Does "ESR" of the intestine measure the liver dysfunction too?.

Jena A, Sharma V, Dutta U Indian J Gastroenterol. 2023; 42(6):754-756.

PMID: 37999894 DOI: 10.1007/s12664-023-01481-2.


Novel diagnostic markers for periprosthetic joint infection: a systematic review.

Schindler M, Walter N, Maderbacher G, Sigmund I, Alt V, Rupp M Front Cell Infect Microbiol. 2023; 13:1210345.

PMID: 37529352 PMC: 10388554. DOI: 10.3389/fcimb.2023.1210345.

References
1.
Josifovikj F, Stardelova K, Todorovska B, Dimitrova M, Joksimovikj N, Andreevski V . Diagnostic Potential of Calprotectin for Spontaneous Bacterial Peritonitis in Patients Withliver Cirrhosis and Ascites. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2022; 42(3):97-106. DOI: 10.2478/prilozi-2021-0040. View

2.
Rimola A, Garcia-Tsao G, Navasa M, Piddock L, Planas R, Bernard B . Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol. 2000; 32(1):142-53. DOI: 10.1016/s0168-8278(00)80201-9. View

3.
Srivastava A, Malik R, Bolia R, Yachha S, Poddar U . Prevalence, Clinical Profile, and Outcome of Ascitic Fluid Infection in Children With Liver Disease. J Pediatr Gastroenterol Nutr. 2016; 64(2):194-199. DOI: 10.1097/MPG.0000000000001348. View

4.
Bender M, Hartmann L, Anemuller J, Schepp W, Gundling F . Calprotectin as Diagnostic Marker for Hepatic Encephalopathy and Spontaneous Bacterial Peritonitis in Cirrhosis. Clin Lab. 2020; 66(6). DOI: 10.7754/Clin.Lab.2019.190934. View

5.
Parsi M, Saadeh S, Zein N, Davis G, Lopez R, Boone J . Ascitic fluid lactoferrin for diagnosis of spontaneous bacterial peritonitis. Gastroenterology. 2008; 135(3):803-7. DOI: 10.1053/j.gastro.2008.05.045. View